Anti-Bacterial Activity of Green Synthesised Silver and Zinc Oxide Nanoparticles against Propionibacterium acnes

Hafez Al-Momani1, Muhannad I Massadeh2, Muna Almasri2

  • 1Department of Microbiology, Pathology and Forensic Medicine, Faculty of Medicine, The Hashemite University, Zarqa 13133, Jordan.

PubMed

Insights

Silver (Ag-NPs) and zinc oxide nanoparticles (ZnO-NPs) show antibacterial effects against antibiotic-resistant Propionibacterium acnes strains. These nanoparticles inhibited bacterial growth and biofilm formation, offering potential alternatives for acne treatment.

Area of Science:

  • Nanotechnology
  • Microbiology
  • Dermatology

Background:

  • Propionibacterium acnes (P. acnes) is a key factor in acne vulgaris development.
  • Increasing antibiotic resistance in P. acnes necessitates novel antimicrobial agents.
  • Silver nanoparticles (Ag-NPs) and zinc oxide nanoparticles (ZnO-NPs) show promise against resistant bacteria.

Purpose of the Study:

  • To investigate the antimicrobial and anti-biofilm effects of green-synthesized Ag-NPs and ZnO-NPs against clinical P. acnes strains.
  • To determine the minimal inhibitory concentrations (MICs) of these nanoparticles.
  • To evaluate their efficacy in inhibiting bacterial growth and biofilm development.

Main Methods:

  • Green synthesis of Ag-NPs and ZnO-NPs using Peganum harmala.
  • Microtiter plate method to assess effects on bacterial growth and biofilm formation.
  • Broth microdilution to determine MIC values.

Main Results:

  • Ag-NPs and ZnO-NPs exhibited spherical shapes with average sizes of 10 nm and 50 nm, respectively.
  • MIC values were 125 µg/mL for Ag-NPs and 250 µg/mL for ZnO-NPs against all P. acnes strains.
  • Significant inhibition of growth and biofilm formation was observed at specific nanoparticle concentrations, with notable effects on clinical strains.

Conclusions:

  • Ag-NPs and ZnO-NPs demonstrate significant antibacterial and anti-biofilm activity against P. acnes.
  • These nanoparticles represent potential therapeutic agents for acne vulgaris, particularly against antibiotic-resistant strains.
  • Further research is warranted to explore their clinical applicability in acne treatment.